Olav Hellebø’s career in pharma began almost by chance, but has since taken him across continents, from the boardrooms of UCB, Novartis, and Schering-Plough, to the cutting edge of cell therapy in his latest role on the Board of Directors at Blue Cell Therapeutics. In this conversation, he reflects on his journey from a business student in Norway to a global biotech leader, sharing insights on leadership, innovation, and the evolving future of medicine. His story is one of curiosity, courage, and a belief that fairness and focus can drive both people and progress.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
